Find out what cybersecurity leaders in healthcare and life sciences organizations can do right now to stay ahead of technology and business risks.

The progress being made to incorporate generative AI into all aspects of healthcare could be seen and heard throughout the halls at HIMSS24.

“Creating Tomorrow’s Health” is the theme of HIMSS24, a global conference, and figuring out how to move AI from pilots to deployment will take center stage.

Erik Barnett outlines five areas within healthcare and life sciences where the U.S. executive order and federal support for responsible AI principles could impact deployment of generative AI in the U.S.

Explore why providers and care teams need an AI Copilot to make the workplace better and focus on what matters most.

The potential in health and life sciences for ChatGPT and open AI, more generally called generative AI, is enormous, but like any other technology, we need to identify how to leverage it and how to get started.

The metaverse brings decentralized business processes together in a virtual world and is one reason why blockchain is the next big thing for life sciences in the metaverse.

Digitalization is top of mind for health and life science leaders attending HIMSS22 European Health Conference and Exhibition.

At Avanade, why we are looking forward to engaging with the European health community at the 2022 HIMSS European Health Conference & Exhibition.

HIMSS 22 had a buzz and energy that signified the health industry’s emergence from a paralyzing pandemic into a "Reimagine and Rethink Health" for the future mindset.